Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2015

01-10-2015 | Short Research Report

A retrospective study of cutaneous drug reactions in an outpatient population

Authors: Francesco Drago, Ludovica Cogorno, Arianna Fay Agnoletti, Giulia Ciccarese, Aurora Parodi

Published in: International Journal of Clinical Pharmacy | Issue 5/2015

Login to get access

Abstract

Background Adverse cutaneous drug reactions (ACDR) are unexpected cutaneous changes occurring at drug dosages that are normally used for disease prophylaxis, diagnosis or treatment. Objective The aim of the study was to determine the clinical types of ACDR, the causative agents, the latency time between drug intake and onset of ACDR and the recovery time in an outpatient population.Method Ninety-five patients diagnosed with ACDR at the Department of Dermatology of the University of Genoa between 2003 and 2012 were retrospectively studied. Results Antimicrobials, especially cephalosporins, were the most responsible for ACDR, followed by non-steroidal anti-inflammatory drugs and antihypertensives. The most common clinical manifestations were exanthema (42.1 %), erythema multiforme (10.53 %) and vasculitis (9.53 %). Patients with peripheral eosinophilia showed a more severe clinical manifestation, they were treated with systemic therapies and their recovery time was longer. Conclusion It is important to have an appropriate clinical approach according to the ACDR severity degree. We think that eosinophilia may characterise severe cutaneous eruptions and that it should always be investigated when ACDR is suspected in order to manage the patient with the appropriate treatment.
Literature
1.
go back to reference Edwards RI, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.CrossRefPubMed Edwards RI, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.CrossRefPubMed
2.
go back to reference McKenna JK, Leiferman KM. Dermatologic drug reactions. Immunol Allergy Clin North Am. 2004;399–423. McKenna JK, Leiferman KM. Dermatologic drug reactions. Immunol Allergy Clin North Am. 2004;399–423.
3.
go back to reference Shear HN, Knowles RS, Sullivan RJ, Shapiro L. Chapter 138, Cutaneous reactions to drugs. Fitzpatrick T, Eisen A, Wolffe K, editors. Dermatology in General Medicine, 8th ed. New York: Mc Graw Hill, p. 1330–1337. Shear HN, Knowles RS, Sullivan RJ, Shapiro L. Chapter 138, Cutaneous reactions to drugs. Fitzpatrick T, Eisen A, Wolffe K, editors. Dermatology in General Medicine, 8th ed. New York: Mc Graw Hill, p. 1330–1337.
4.
5.
go back to reference Zaraa I, Jones M, Trojjet S, Cheikh Rouhou R, El Euch D, Mokni M, et al. Severe adverse cutaneous drug eruptions: epidemiological and clinical features. Int J Dermatol. 2011;50:877–80.CrossRefPubMed Zaraa I, Jones M, Trojjet S, Cheikh Rouhou R, El Euch D, Mokni M, et al. Severe adverse cutaneous drug eruptions: epidemiological and clinical features. Int J Dermatol. 2011;50:877–80.CrossRefPubMed
6.
go back to reference Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev. 2000;53:357–79. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev. 2000;53:357–79.
7.
go back to reference Apaydin R, Bilen N, Dökmeci S, Bayramgürler D, Yildirim G. Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital. Eur Acad Dermatol Venereol. 2000;14:518–20.CrossRef Apaydin R, Bilen N, Dökmeci S, Bayramgürler D, Yildirim G. Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital. Eur Acad Dermatol Venereol. 2000;14:518–20.CrossRef
9.
go back to reference Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Investig Dermatol. 2000;115:149–53.CrossRefPubMed Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Investig Dermatol. 2000;115:149–53.CrossRefPubMed
Metadata
Title
A retrospective study of cutaneous drug reactions in an outpatient population
Authors
Francesco Drago
Ludovica Cogorno
Arianna Fay Agnoletti
Giulia Ciccarese
Aurora Parodi
Publication date
01-10-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0134-z

Other articles of this Issue 5/2015

International Journal of Clinical Pharmacy 5/2015 Go to the issue